{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T21:14:29Z","timestamp":1770153269426,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.metop.2022.100191","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T01:46:38Z","timestamp":1653270398000},"page":"100191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A comparative evaluation of cardiac and neurological safety status of two commonly used oral hypoglycaemic agents in T2-DM Swiss albino mice model"],"prefix":"10.1016","volume":"14","author":[{"given":"Md. Ohidur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaheen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanoy","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Abdus","family":"Salam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prodip Kumar","family":"Baral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Faruk","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuvo","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayem","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubiya","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8551-0039","authenticated-orcid":false,"given":"Md. Saddam","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metop.2022.100191_bib1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/ijcp.12605","article-title":"Effectiveness and safety of glimepiride and iDPP4, associated with metformin in second line pharmacotherapy of type 2 diabetes mellitus: systematic review and meta-Analysis","volume":"69","author":"Amate","year":"2015","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.metop.2022.100191_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metop.2022.100191_bib3","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2174\/1381612823666170317165350","article-title":"Diabetes-Related neurological implications and pharmacogenomics","volume":"24","author":"Rojas-Carranza","year":"2018","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.metop.2022.100191_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-014-0512-5","article-title":"Role of HDL in those with diabetes","volume":"16","author":"Santos-Gallego","year":"2014","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.metop.2022.100191_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4093\/dmj.2012.36.1.6","article-title":"Diabetic peripheral neuropathy in type 2 diabetes mellitus in Korea","volume":"36","author":"Ko","year":"2012","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.metop.2022.100191_bib6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbrc.2016.05.148","article-title":"Metformin preconditioning provide neuroprotection through enhancement of autophagy and suppression of inflammation and apoptosis after spinal cord injury","volume":"477","author":"Wang","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metop.2022.100191_bib7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.bbadis.2015.01.006","article-title":"The neuroprotective role of metformin in advanced glycation end product treated human neural stem cells is AMPK-dependent","volume":"1852","author":"Chung","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metop.2022.100191_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/14737175.2021.1847645","article-title":"Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system","volume":"21","author":"Demar\u00e9","year":"2021","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.metop.2022.100191_bib9","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","article-title":"Metformin \u2013 a future therapy for neurodegenerative diseases","volume":"34","author":"Markowicz-Piasecka","year":"2017","journal-title":"Pharm Res"},{"key":"10.1016\/j.metop.2022.100191_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2174\/156801305774962123","article-title":"The mode of action of the antidiabetic drug glimepiride-beyond insulin secretion","volume":"5","author":"M\u00fcller","year":"2005","journal-title":"Curr Med Chem Immunol Endocr Metab Agents"},{"key":"10.1016\/j.metop.2022.100191_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0149-2918(03)80109-1","article-title":"Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience","volume":"25","author":"Massi-Benedetti","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.metop.2022.100191_bib12","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2337\/db12-0988","article-title":"The DPP-4 inhibitor linagliptin counteracts stroke in the normal and diabetic mouse brain: a comparison with glimepiride","volume":"62","author":"Darsalia","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.metop.2022.100191_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2147\/VHRM.S33194","article-title":"Glimepiride: evidence-based facts, trends, and observations","volume":"8","author":"Basit","year":"2012","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.metop.2022.100191_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000381643","article-title":"Metformin: an old drug for the treatment of diabetes but a new drug for the protection of the endothelium","volume":"24","author":"Kinaan","year":"2015","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.metop.2022.100191_bib15","first-page":"51","article-title":"Studies on the extraction process of total flavonoids in Radix puerariae and their hypoglycemic effect in mice","volume":"26","author":"Hui","year":"2015","journal-title":"Biomed Res"},{"key":"10.1016\/j.metop.2022.100191_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrep.2021.100990","article-title":"Comparative lipid and uric acid suppressing properties of four common herbs in high fat-induced obese mice with their total phenolic and flavonoid index","volume":"26","author":"Mazumder","year":"2021","journal-title":"Biochem Biophys Reports"},{"key":"10.1016\/j.metop.2022.100191_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbacli.2015.01.005","article-title":"High density lipoproteins: measurement techniques and potential biomarkers of cardiovascular risk","volume":"3","author":"Hafiane","year":"2015","journal-title":"BBA Clin"},{"key":"10.1016\/j.metop.2022.100191_bib18","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12944-021-01471-3","article-title":"Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson's, Martin's and Friedewald's equations","volume":"20","author":"Vargas-V\u00e1zquez","year":"2021","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metop.2022.100191_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/cpdd.767","article-title":"Evaluation of pharmacokinetics and dose proportionality of diazepam after intranasal administration of NRL-1 to healthy volunteers","volume":"9","author":"Tanimoto","year":"2020","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.metop.2022.100191_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2710.2006.00766.x","article-title":"Pharmacokinetic and pharmacodynamic modelling of the effects of glimepiride on insulin secretion and glucose lowering in healthy humans","volume":"31","author":"Yun","year":"2006","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.metop.2022.100191_bib21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-199630050-00003","article-title":"Clinical pharmacokinetics of metformin","volume":"30","author":"Scheen","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.metop.2022.100191_bib22","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/ptr.6953","article-title":"Behavioral and neurological improvement by Cydonia oblonga fruit extract in chronic immobilization stress rats","volume":"35","author":"Sakhri","year":"2021","journal-title":"Phyther Res"},{"key":"10.1016\/j.metop.2022.100191_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/biom10040561","article-title":"Intervention in neuropsychiatric disorders by suppressing inflammatory and oxidative stress signal and exploration of in silico studies for potential lead compounds from holigarna caustica (Dennst.) oken leaves","volume":"10","author":"Adnan","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.metop.2022.100191_bib24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","article-title":"The use of the elevated plus maze as an assay of anxiety-related behavior in rodents","volume":"2","author":"Walf","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.metop.2022.100191_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/2221-1691.259002","article-title":"Neuropharmacological evaluation of methanolic extract of Costus speciosus Linn. rhizome in Swiss albino mice","volume":"9","author":"Chen","year":"2019","journal-title":"Asian Pac J Trop Biomed"},{"key":"10.1016\/j.metop.2022.100191_bib26","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.metabol.2014.08.010","article-title":"Diabetic dyslipidemia","volume":"63","author":"Wu","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metop.2022.100191_bib27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jcem.86.3.7304","article-title":"Diabetic dyslipidemia - causes and consequences","volume":"86","author":"Goldberg","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metop.2022.100191_bib28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-2275(20)37569-6","article-title":"Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis","volume":"37","author":"Goldberg","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metop.2022.100191_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2362.1996.114256.x","article-title":"Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis","volume":"26","author":"De Man","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.metop.2022.100191_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Crosby","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metop.2022.100191_bib31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3389\/fphar.2018.01099","article-title":"Antihyperglycemic and antihyperlipidemic effects of aqueous extracts of lannea edulis in alloxan-induced diabetic rats","volume":"9","author":"Banda","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.metop.2022.100191_bib32","first-page":"E208","article-title":"New insight into metformin-induced cholesterol-lowering effect","volume":"41","author":"Hu","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metop.2022.100191_bib33","doi-asserted-by":"crossref","first-page":"16430","DOI":"10.1038\/srep16430","article-title":"Metformin inhibits hepatocellular glucose, lipid and cholesterol biosynthetic pathways by transcriptionally suppressing steroid receptor coactivator 2 (SRC-2)","volume":"5","author":"Madsen","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.metop.2022.100191_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1758-5996-5-70","article-title":"Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials","volume":"5","author":"Zhu","year":"2013","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.metop.2022.100191_bib35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2337\/dc06-1554","article-title":"Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study","volume":"30","author":"Gottschalk","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metop.2022.100191_bib36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.metabol.2008.09.006","article-title":"Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus","volume":"58","author":"Araki","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.metop.2022.100191_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.diabres.2009.12.010","article-title":"Effects of Glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus","volume":"88","author":"yan Xu","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metop.2022.100191_bib38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1529-8027.2009.00237.x","article-title":"Hyperlipidemia: a new therapeutic target for diabetic neuropathy","volume":"14","author":"Vincent","year":"2009","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.metop.2022.100191_bib39","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.2337\/db09-0047","article-title":"Dyslipidemia-induced neuropathy in mice: the role of oxLDL\/LOX-1","volume":"58","author":"Vincent","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.metop.2022.100191_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11745-010-3401-8","article-title":"Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol","volume":"45","author":"Nakhjavani","year":"2010","journal-title":"Lipids"},{"key":"10.1016\/j.metop.2022.100191_bib41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bph.14519","article-title":"Metformin produces anxiolytic-like effects in rats by facilitating GABAA receptor trafficking to membrane","volume":"176","author":"Fan","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metop.2022.100191_bib42","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.12659\/MSM.911250","article-title":"Neuro-Protective role of metformin in patients with acute stroke and type 2 diabetes mellitus via ampk\/mammalian target of rapamycin (mTOR) signaling pathway and oxidative stress","volume":"25","author":"Zhao","year":"2019","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.metop.2022.100191_bib43","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fneur.2020.00556","article-title":"Metformin as a potential neuroprotective agent in prodromal Parkinson's disease\u2014viewpoint","volume":"11","author":"Sportelli","year":"2020","journal-title":"Front Neurol"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936822000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936822000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:58:09Z","timestamp":1762905489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589936822000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":43,"alternative-id":["S2589936822000299"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2022.100191","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative evaluation of cardiac and neurological safety status of two commonly used oral hypoglycaemic agents in T2-DM Swiss albino mice model","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2022.100191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100191"}}